The von Hippel Lindau tumor suppressor limits longevity

Journal of the American Society of Nephrology

Volumn 20, Issue 12, 2009, Pages 2513-2517

  Müller, Roman Ulrich ^a   Fabretti, Francesca ^a   Zank, Sibylle ^a   Burst, Volker ^a   Benzing, Thomas ^a   Schermer, Bernhard ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SOMATOMEDIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR DAF 16; TRANSCRIPTION FACTOR FOXO; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CAENORHABDITIS ELEGANS; CARCINOGENESIS; CONTROLLED STUDY; GENE MUTATION; KIDNEY CARCINOMA; LIFESPAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE REGENERATION; WESTERN BLOTTING;

EID: 72049106682     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009050497     Document Type: Article

References (38)

1. Kaelin WG Jr: The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res 10: 6290S-6295S, 2004
2. Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr: Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1: 822-826, 1995
3. Schoenfeld A, Davidowitz EJ, Burk RD: A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci U S A 95: 8817-8822, 1998 (Pubitemid 28350572)
4. Kaelin WG Jr: The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol 14: 2703-2711, 2003
5. Mandriota SJ, Turner KJ, Davies DR, Murray PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe PJ, Maxwell PH: HIF activation identifies early lesions in VHL kidneys: Evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1: 459-468, 2002
6. Esteban MA, Harten SK, Tran MG, Maxwell PH: Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J Am Soc Nephrol 17: 1801-1806, 2006
7. Lutz MS, Burk RD: Primary cilium formation requires von Hippel-Lindau gene function in renal-derived cells. Cancer Res 66: 6903-6907, 2006
8. Schermer B, Ghenoiu C, Bartram M, Muller RU, Kotsis F, Hohne M, Kuhn W, Rapka M, Nitschke R, Zentgraf H, Fliegauf M, Omran H, Walz G, Benzing T: The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth. J Cell Biol 175: 547-554, 2006
9. Thoma CR, Frew IJ, Krek W: The VHL tumor suppressor: Riding tandem with GSK3beta in primary cilium maintenance. Cell Cycle 6: 1809-1813, 2007
10. Schraml P, Frew IJ, Thoma CR, Boysen G, Struckmann K, Krek W, Moch H: Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Mod Pathol 22: 31-36, 2009
11. Chen D, Thomas EL, Kapahi P: HIF-1 modulates dietary restriction-mediated lifespan extension via IRE-1 in Caenorhabditis elegans. PLoS Genet 5: e1000486, 2009
12. Mehta R, Steinkraus KA, Sutphin GL, Ramos FJ, Shamieh LS, Huh A, Davis C, Chandler-Brown D, Kaeberlein M: Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 324: 1196-1198, 2009
13. Finch CE, Ruvkun G: The genetics of aging. Annu Rev Genomics Hum Genet 2: 435-462, 2001
14. Partridge L: Some highlights of research on aging with invertebrates, 2008. Aging Cell 7: 605-608, 2008
15. Tatar M, Bartke A, Antebi A: The endocrine regulation of aging by insulin-like signals. Science 299: 1346-1351, 2003 (Pubitemid 36254639)
16. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G: The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994-999, 1997 (Pubitemid 27485694)
17. Henderson ST, Johnson TE: daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol 11: 1975-1980, 2001
18. Partridge L, Bruning JC: Forkhead transcription factors and ageing. Oncogene 27: 2351-2363, 2008
19. Gottlieb S, Ruvkun G: daf-2, daf-16 and daf-23: Genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. Genetics 137: 107-120, 1994
20. Mizuno T, Hisamoto N, Terada T, Kondo T, Adachi M, Nishida E, Kim DH, Ausubel FM, Matsumoto K: The Caenorhabditis elegans MAPK phosphatase VHP-1 mediates a novel JNK-like signaling pathway in stress response. EMBO J 23: 2226-2234, 2004 (Pubitemid 38833232)
21. Neumann-Haefelin E, Qi W, Finkbeiner E, Walz G, Baumeister R, Hertweck M: SHC-1/p52Shc targets the insulin/IGF-1 and JNK signaling pathways to modulate life span and stress response in C. elegans. Genes Dev 22: 2721-2735, 2008
22. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH: p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet 2: e183, 2006
23. Wolf M, Nunes F, Henkel A, Heinick A, Paul RJ: The MAP kinase JNK-1 of Caenorhabditis elegans: Location, activation, and influences over temperature-dependent insulin-like signaling, stress responses, and fitness. J Cell Physiol 214: 721-729, 2008 (Pubitemid 351224217)
24. Wang MC, Bohmann D, Jasper H: JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121: 115-125, 2005 (Pubitemid 40501172)
25. Berman K, McKay J, Avery L, Cobb M: Isolation and characterization of pmk-(1-3): Three p38 homologs in Caenorhabditis elegans. Mol Cell Biol Res Commun 4: 337-344, 2001 (Pubitemid 33098104)
26. Antebi A: Genetics of aging in Caenorhabditis elegans. PLoS Genet 3: 1565-1571, 2007
27. Friedman DB, Johnson TE: A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 118: 75-86, 1988
28. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang RA: C. elegans mutant that lives twice as long as wild type. Nature 366: 461-464, 1993 (Pubitemid 24013878)
29. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G: daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946, 1997
30. Morris JZ, Tissenbaum HA, Ruvkun G: A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382: 536-539, 1996
31. Campisi J, Sedivy J: How does proliferative homeostasis change with age? What causes it and how does it contribute to aging? J Gerontol A Biol Sci Med Sci 64: 164-166, 2009
32. Collado M, Blasco MA, Serrano M: Cellular senescence in cancer and aging. Cell 130: 223-233, 2007
33. Serrano M: Cancer regression by senescence. N Engl J Med 356: 1996-1997, 2007
34. Rodier F, Kim SH, Nijjar T, Yaswen P, Campisi J: Cancer and aging: The importance of telomeres in genome maintenance. Int J Biochem Cell Biol 37: 977-990, 2005 (Pubitemid 40311740)
35. Haase VH: The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease. Kidney Int 69: 1302-1307, 2006
36. Brenner S: The genetics of Caenorhabditis elegans. Genetics 77: 71-94, 1974
37. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998
38. Boehm M, Slack F: A developmental timing microRNA and its target regulate life span in C. elegans. Science 310: 1954-1957, 2005